Caricamento...
Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases
BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) is a serine protease that inhibits the degradation of glucagon-like peptide 1. DPP-4 inhibitors are used worldwide to treat type 2 diabetes mellitus and were recently shown to have pleiotropic effects such as anti-oxidant, anti-inflammatory, and anti-fibrot...
Salvato in:
| Pubblicato in: | BMC Nephrol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7501714/ https://ncbi.nlm.nih.gov/pubmed/32948146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-020-02060-9 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|